Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Tropical Protozoan Disease Treatment Drugs"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 20 September 2023 | Viewed by 1759
Special Issue Editors
Interests: antiprotozoal activity; chemotherapy; drug discovery; treatment schedule; tropical infectious diseases
Interests: drug discovery; drug design; chemotherapy; pharmacokinetics; treatment schedule
Interests: antiprotozoal activity; chemotherapy; drug discovery; protozoan parasites; tropical infectious diseases
Special Issue Information
Tropical diseases caused by protozoan parasites – such as Trypanosoma cruzi, Trypanosoma brucei, Leishmania spp. or Plasmodium spp., among others – affect million of people worldwide, causing more than a million human deaths and disabilities annually and high economic and social burden.
These pathogens have complex life cyles involving different morphological stages, sometimes within different vertebrate and invertebrate hosts. In addition, the diseases caused by these pathogens leads to complex pathology and long-term nature.
Many current drugs to combat these diseases have several disadvantages such as limited efficacy, severe side effects, requirement for long treatment periods, development of resistance, and high cost. Therefore, the search for new drugs and therapeutic strategies to combat these pathogens are urgently required.
Authors are kindly invite to submit original papers, communications and reviews regarding drug design, drug discovery, drug delivery, pharmacokinetics, pharmacodinamics and related topics, to be published in this Special Issue of Pharmaceutics.
Dr. Rubén Martín-Escolano
Dr. Encarnación Medina Carmona
Prof. Dr. Clotilde Marín Sánchez
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antiprotozoal activity
- drug delivery
- drug design
- drug discovery
- protozoan parasites
- treatment schedule
- tropical infectious diseases